TIBI

TargetMol
Product Code: TAR-T28973
Supplier: TargetMol
CodeSizePrice
TAR-T28973-50mg50mg£644.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28973-100mg100mg£986.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
TIBI is a potent, ATP-competitive inhibitor of CK2 and Rio1.
CAS:
1196457-06-3
Formula:
C7H2I4N2
Molecular Weight:
621.725
Purity:
0.98
SMILES:
Ic1c(I)c(I)c2[nH]cnc2c1I

References

1. Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Rickelt J, Schruers KRJ, Anholt GE. The long-term association of OCD and depression and its moderators: A four-year follow up study in a large clinical sample. Eur Psychiatry. 2017 Apr 7;44:76-82. doi: 10.1016/j.eurpsy.2017.03.009. [Epub ahead of print] PubMed PMID: 28545012. 2. Buckert D, Cieslik M, Tibi R, Radermacher M, Rottbauer W, Bernhardt P. Cardiac magnetic resonance imaging derived quantification of myocardial ischemia and scar improves risk stratification and patient management in stable coronary artery disease. Cardiol J. 2017 Mar 29. doi: 10.5603/CJ.a2017.0036. [Epub ahead of print] PubMed PMID: 28353309. 3. Jurj A, Tomuleasa C, Tat TT, Berindan-Neagoe I, Vesa SV, Ionescu DC. Antiproliferative and Apoptotic Effects of Lidocaine on Human Hepatocarcinoma Cells. A preliminary study. J Gastrointestin Liver Dis. 2017 Mar;26(1):45-50. doi: 10.15403/jgld.2014.1121.261.juj. PubMed PMID: 28338113. 4. Shao Z, Al Tibi M, Wakim-Fleming J. Update on viral hepatitis in pregnancy. Cleve Clin J Med. 2017 Mar;84(3):202-206. doi: 10.3949/ccjm.84a.15139. Review. PubMed PMID: 28322675.